Evidence map›Paper›PMID 19446279›Full record

ReviewTranslational research : the journal of laboratory and clinical medicine2009

Role of endothelin-1 in acute lung injury.

Alejandro P Comellas, Arturo Briva

Registry-linked trialAbstract readReview
In one paragraph

Review in Translational research : the journal of laboratory and clinical medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04771000 (A Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Ambrisentan in Patients With Severe COVID-19), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04771000 phase2terminatednot on this mapstarted 2021, after this paper: background citation

A Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Ambrisentan in Patients With Severe COVID-19

TypeinterventionalSponsorNoorik Biopharmaceuticals AGRan2021 to 2023Enrolled88ConditionsCovid19, HypoxemiaArmsAmbrisentan, Placebo
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Biomarkers in pediatric acute respiratory distress syndrome.Annals of translational medicine · 2019
    Review
  11. Endothelin-1 mediates Aspergillus fumigatus-induced airway inflammation and remodelling.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Article
  12. Review
  13. Review
  14. Cortical Actin Dynamics in Endothelial Permeability.Current topics in membranes · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Alejandro P ComellasDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa 52242, USA. alejandro-comellas@uiowa.edu
Arturo Briva
Universidad de la República · UYUniversity of Iowa · US

Funding

Hypoxia Disrupts the Alveolar Barrier: Role of ClaudinsK01HL080966 · NHLBI · UNIVERSITY OF IOWA · PI COMELLAS, ALEJANDRO PIERRE · 2006 to 2010
$665k
NHLBI NIH HHS K01 HL080966NHLBI NIH HHS K01HL080966-01
6 · The paper itself

Abstract

The alveolar-capillary membrane serves as a barrier that prevents the accumulation of fluid in the alveolar space and restricts the diffusion of large solutes while facilitating an efficient gas exchange. When this barrier becomes dysfunctional, patients develop acute lung injury (ALI), which is characterized by pulmonary edema and increased lung inflammation that leads to a life-threatening impairment of gas exchange. In addition to the increase of inflammatory cytokines, plasma levels of endothelin-1 (ET-1), which is a primarily endothelium-derived vasoconstrictor, are increased in patients with ALI. As patients recover, ET-1 levels decrease, which suggests that ET-1 may not only be a marker of endothelial dysfunction but may have a role in the pathogenesis of ALI. While pulmonary edema accumulates, alveolar fluid clearance (AFC) is of critical importance, as failure to return to normal clearance is associated with poor prognosis in patients with pulmonary edema. AFC involves active transport mechanisms where sodium (Na(+)) is actively transported from the alveolar airspaces, across the alveolar epithelium, and into the pulmonary circulation, which creates an osmotic gradient that is responsible for the clearance of lung edema. In this article, we review the relevance of ET-1 in the development of ALI, not only as a vasoconstrictor molecule but also by inhibiting AFC via the activation of endothelial ET-B receptors and generation. Furthermore, this review highlights the therapeutic role of drugs such as beta-adrenergic agonists and, in particular, of endothelin receptor antagonists in patients with ALI.

Indexed as

Acute Lung InjuryAdrenergic beta-AgonistsEndothelin-1Endothelin Receptor AntagonistsHumansAdrenergic beta-AgonistsEndothelin-1Endothelin Receptor Antagonists

Identifiers

PMID19446279
PMCPMC3046772
OpenAlexW2132669112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.